A 14-year-old girl with newly diagnosed osteosarcoma of the proximal tibia is being staged prior to chemotherapy. Plain radiographs and MRI of the knee have been completed. Which investigation is most appropriate as the next step to detect occult metastatic disease?

Explanation

## Metastatic Staging in Osteosarcoma ### Why CT Chest Is the Gold Standard for Staging **Key Point:** High-resolution CT chest with contrast is the investigation of choice for detecting pulmonary metastases in osteosarcoma. Lung metastases occur in ~20% of patients at presentation and are the most common site of distant spread. **High-Yield:** Osteosarcoma metastatic pattern: - Lungs: 80–90% of metastatic disease - Bone: 10–15% (skip lesions, distant bones) - Liver, brain: rare at presentation ### Why CT Chest Over Other Modalities? ```mermaid flowchart TD A[Osteosarcoma diagnosed]:::outcome --> B{Staging investigations}:::decision B -->|Lung metastases?| C[High-resolution CT chest]:::action B -->|Skeletal metastases?| D[Whole-body bone scan]:::action B -->|Metabolic activity?| E[PET-CT]:::action C --> F[Detects nodules ≥3-5 mm]:::outcome D --> G[Detects osteoblastic lesions]:::outcome E --> H[Research/advanced staging]:::outcome F -->|Superior sensitivity| I[CT is standard of care]:::action ``` **Clinical Pearl:** CT chest detects nodules as small as 3–5 mm with high sensitivity (~95%), whereas chest radiographs miss lesions <1 cm. This is critical because even small pulmonary nodules may harbor micrometastases. ### Comparison of Staging Investigations | Investigation | Sensitivity for Lung Mets | Sensitivity for Bone Mets | Clinical Role | |---|---|---|---| | **CT chest (high-res)** | **95%** | **No** | **Gold standard for lung staging** | | Chest X-ray | ~60% | — | Insufficient; misses small nodules | | Bone scan | — | ~80% | Detects osteoblastic lesions (skip mets) | | PET-CT | ~90% | ~85% | Research tool; not standard of care | | Abdominal ultrasound | — | — | No role in osteosarcoma staging | ### Timing of Staging Investigations 1. **Local staging:** MRI of primary (soft tissue, skip lesions) 2. **Pulmonary staging:** CT chest (most common site of spread) 3. **Skeletal staging:** Bone scan (if skip lesions suspected) or PET-CT (advanced centers) 4. **Treatment:** Neoadjuvant chemotherapy → surgery → adjuvant chemotherapy **Warning:** Chest X-ray alone is inadequate for staging. It misses 30–40% of pulmonary nodules <1 cm, which may contain viable tumor cells. ### Why Other Options Are Not First-Line - **PET-CT:** Useful for detecting metabolically active lesions but not standard of care for initial staging. Reserved for research or detecting recurrent disease. - **Bone scan:** Used to detect skeletal metastases (skip lesions) but is secondary to CT chest. Often omitted if MRI already excludes skip lesions. - **Abdominal ultrasound:** No role in osteosarcoma staging; liver metastases are rare at presentation.